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Abstract: The aim of this study was to perform a 3-year follow-up of primary
somatoform vertigo and dizziness (SVD) regarding health care use and treat-
ment. Ninety-two patients with dizziness underwent detailed vestibular neuro-
physiological testing and a Structured Clinical Interview for Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition. Psychometric assess-
ments comprised the Vertigo Symptom Scale, the Vertigo Handicap Question-
naire, the SCL-90-R, and the Short-FormY36 Health Survey. At the 3-year
follow-up, 65 patients with primary SVD (anxiety, n = 29; depression, n = 14;
somatoform disorders, n = 22) were reassessed (70.7% response). The patients
improved in symptom severity (p G 0.05), handicap (p G 0.01), and physical
quality of life (QoL; p G 0.05) but showed no change in emotional distress. A
total of 63.1% (of n = 65) had ongoing SVD. A total of 69.2% (of n = 65) re-
ceived different forms of treatments. A total of 46.1% (of n = 65) searched re-
dundant medical diagnostic procedures. The patients with decreased coping
capacity over time obtained the best prognosis. Primary SVD is an ineffectively
treated disorder. Recommendations for specific complaint-oriented psychother-
apy programs were given.
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P rimary somatoform vertigo and dizziness (SVD) as a correlate ofa psychopathological process is a common diagnosis in psycho-
somatic health care (Kroenke et al., 2000; Staab and Ruckenstein,
2007b). Primary SVD is defined as the superordinate classification
of different mental subgroups (anxiety, depressive, or somatoform
disorders). Diagnostically, no vestibular deficit or dysfunction in
medical history could be found. Trigger factors for the onset of SVD
can result from critical life events, emotional distress, or relational
or psychodynamic conflicts (Eckhardt-Henn and Dieterich, 2005;
Yardley, 2000).
In contrast to primary SVD, secondary SVD is defined as a
mental comorbidity after an initial (and meanwhile centrally compen-
sated or peripheral remitted) vestibular disorder resulting from indi-
vidual maladaptive coping (Best et al., 2009). For example, phobic
postural vertigo as a subtype of secondary SVD can be a result of
catastrophizing beliefs and anxious avoidance during states of vertigo
attacks (Huppert et al., 2005; Kapfhammer et al., 1997).
Epidemiologically, more than 30% of all patients with vertigo
or dizziness have primary SVD (Kroenke et al., 2000). Thereof, 45%
showed comorbid anxiety; 30%, depressive disorder; and 25%,
somatoform disorders (Eckhardt-Henn et al., 2003). Recent studies
explored specific epidemiological data for vertigo or dizziness in
community-based and primary careYbased settings. Prevalence rates
range from 20% up to 30% of affected people in the general popula-
tion (Nazareth et al., 2006; Neuhauser et al., 2008;Wiltink et al., 2009).
Up to 80% of vertigo or dizziness resulted in medical consultations,
restrictions of daily activities, or sick leaves (Nazareth et al., 2006;
Neuhauser et al., 2005). In a UK sample of working-aged people
with dizziness, 40% seek help through their general practitioners, but
only one third received some form of treatment (Yardley et al., 1998).
Anxiety-induced SVD revealed higher health care use than did vertigo
or dizziness without comorbid anxiety or phobic disorders (Wiltink
et al., 2009). Posing a risk for a chronic course, primary SVD leads to
extensive handicaps and restrictions in quality of life (QoL; Kroenke
et al., 2000; Staab and Ruckenstein, 2007b). Because no dizziness-
specific psychotherapy programs are available, little is known about
health care use and psychotherapeutic outcome. The purpose of this
prospective study was to perform a 3-year follow-up of patients with
primary SVD regarding persistence of symptoms, handicap, and cop-
ing. Clinical characteristics, health care use, treatment, and their im-
plications for psychotherapy programs were analyzed.
PATIENTS AND METHODS
In an interdisciplinary long-term study, we examined a total of
92 consecutive patients with primary SVD during a course of 3 years.
At baseline measurements (T0), 39 patients (42.4%) were diagnosed
with an anxiety disorder (ICD-10: F40, F41); 18 patients (19.6%),
with a depressive disorder (ICD-10: F32, F33, F34.1); and 35 pa-
tients (38%), with a somatoform disorder (ICD-10: F45). The total
sample included 44 women and 48 men; the mean (SD) age was 41.8
(13.3) years. The exclusion criteria were regular intake of any med-
ication affecting the CNS, an acute disease of the CNS, an acute
psychotic disorder, current psychotherapy, and inadequate knowl-
edge of the German language. This study was approved by the local
ethics committee, according to the criteria of the Declaration of
Helsinki (1964). The patients were included in this study after they
had given their written informed consent.
All participants underwent detailed diagnostic procedures (T0)
consisting of a clinical neurological examination; a neuro-orthoptic
analysis; and neurophysiological vestibular laboratory testing includ-
ing an electro-oculography with caloric irrigation (Honrubia, 1994),
measurements of the subjective visual vertical, and determination of
ocular torsion by fundus photographs (Dieterich and Brandt, 1993).
The psychosomatic examination comprised a psychometric test battery
measuring dizziness-related somatic and mental symptoms. Assign-
ment to the different subgroups of SVD was performed using the
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Structured Clinical Interview for Diagnostic and Statistical Manual
of Mental Disorders, Fourth Edition (DSM-IV), Axis I disorders
(Wittchen et al., 1989). After the diagnostic examinations, all patients
with SVD received short psychoeducation and a specific recommen-
dation for psychotherapy. Table 1 gives an overview about the psy-
chotherapeutic interventions.
Survey Questionnaires
The participants were asked to complete a survey question-
naire including sociodemographic data, health care use, and subjec-
tive health outcome. Health care use was assessed by the ‘‘number
of medical disciplines for further diagnostic procedures’’ and by the
‘‘number and forms of treatment.’’ Next to the Vertigo Symptom
Scale (VSS), persistence of SVD was assessed using the question
‘‘Do you currently suffer from ongoing vertigo or dizziness?’’ The
answer format was a 3-point Likert scale ranging from 0, ‘‘no diz-
ziness complaints’’; 1, ‘‘rare dizziness complaints’’; to 2, ‘‘frequent
dizziness complaints.’’
Vertigo Symptom Scale
Vertigo- or dizziness-related symptoms were examined using
the German version of the VSS. The questionnaire consists of 34 items
measuring the frequency and the quality of dizziness (vertigo, imbal-
ance, and diffuse dizziness) and its concomitant symptoms. Two main
subscales can be derived: vertigo and related symptoms (VER) ex-
amines the symptom severity, whereas somatic anxiety and autonomic
arousal (AA) assesses the accompanying anxiety-related symptoms.
As unit of measurement, the sum scores of the two scales are calcu-
lated. The VSS-VER and the VSS-AA have good internal consisten-
cies (Cronbach’s >: VER, 0.79; AA, 0.89; Tschan et al., 2008).
Vertigo Handicap Questionnaire
The Vertigo Handicap Questionnaire (VHQ) measures the
handicapping consequences of vertigo and dizziness, including
disease-specific limitations on physical activities and their impact on
social life and leisure time activities. Some of the items assess social
support, stigmatization, and distress caused by dizziness. It therefore
reflects the restrictions patients experience in their daily life activities
caused by inadequate coping with vertigo or dizziness. The total sum
score ranges from 0 to 100 points (percentage of handicap). The
VHQ has a good internal consistency (Cronbach’s > = 0.92; Tschan
et al., 2010).
The SCL-90-R
The German version of the SCL-90R is a standardized self-
report instrument measuring psychopathology on nine scales: somati-
zation, obsessive-compulsive, interpersonal sensitivity, depression,
anxiety, anger-hostility, phobic anxiety, paranoid ideation, and psy-
choticism. The Global Severity Index (GSI) indicates the dimension of
emotional distress. The subscales have good internal consistencies
(Cronbach’s > = 0.75Y0.97; Franke, 1995).
Short-FormY36 Health Survey
Subjective QoL was assessed using the German version of the
Short-FormY36 Health Survey (SF-36) as an instrument for evaluating
various aspects of health status. It examines two main components by
eight health-related concepts: The physical health component (PHC)
consists of the subscales physical functioning, role-physical, bodily
pain, and general health; the mental health component (MHC) contains
the subscales mental health, role-emotional, social functioning, and
vitality. As unit of measurement, the total sum for both scales is cal-
culated. The subscales have satisfactory to good internal consistencies
(Cronbach’s > = 0.57Y0.97; Bullinger and Kirchberger, 1998).
Statistical Analysis
Statistical analyses were performed by SPSS (Statistical Pack-
age for the Social Sciences) for Windows (version 15.0) by nonpara-
metric (Fisher’s exact test and chi-square test) and parametric
procedures (t-test, analysis of variance [ANOVA]). For post hoc
comparisons, we used the Scheffé’s procedure. We defined the level of
significance at p G 0.05; we additionally report the results with higher
levels of confidence (p G 0.01, p G 0.001). Because of the exploratory
character of this study, we did not perform alpha adjustment.
RESULTS
Dropout Analysis
From baseline to the 3-year follow-up, we could reassess a
total of 65 patients. A total of 29% (n = 27) dropped out because of
the following reasons: no valid address (n = 9) and not interested in
further examination (n = 18). The participants who dropped out were
slightly younger than the participants from the study sample (42.2 vs.
43.7 years; p G 0.05). Table 2 shows the sociodemographic data of
the sample.
With regard to the psychometric data, the participants who
dropped out (n = 27) reported higher levels of global distress (GSI:
T[90] = 2.34; p = 0.021) than did the study sample (n = 65). Moreover,
the participants who dropped out had higher scores on the VER
subscale of the VSS (VSS-VER: T[89] = 2.34; p = 0.021). No signif-
icant differences between the study and the dropout sample could be
obtained regarding QoL (SF-36), dizziness-specific handicap (VHQ),
and the AA subscale of the VSS (VSS-AA).
Distress, QoL, Vertigo, or Dizziness Symptoms and
Handicap Through the 3-Year Follow-up Period
After the 3-year follow-up period, 24 study participants
(36.9% of n = 65 at T1) did not or only seldomly experienced diz-
ziness. Overall, the patients judged their physical health as improved
(p = 0.01), but not their mental health. Global distress (GSI) did not
change during the 3 years. The patients reported that their dizziness-
specific handicap improved (p = 0.001) and that they experienced
fewer vertigo or dizziness-related symptoms (p G 0.05). Somatic AA
TABLE 1. Table of Contents for Psychotherapeutic Short-term
Intervention
Sessions 1Y2 Diagnostic procedures and feedback
a) Initial clinical interview for the diagnosis of SVD
b) Structured Clinical Interview for DSM-IV (SCID-I)
to diagnose the specific subgroup of SVD
c) Feedback about the clinical outcome
Session 3 Disease models and mechanism
a) Psychoeducation about the causes and the
maintaining mechanisms of SVD
b) Psychoeducation about the significant role of stress,
anxiety, and avoidance behavior relating to ongoing
dizziness and decreased QoL
Session 4 Treatment recommendations and their mechanisms
of action
Obligatory: specific recommendations for psychotherapy
a) Cognitive-behavioral or psychodynamic psychotherapy
b) Outpatient or inpatient psychotherapy
Optionally: recommendation for psychopharmacological
treatment (e.g., SSRI), relaxation, or vestibular
rehabilitation
SSRI indicates selective serotonin reuptake inhibitor.
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did not change during the follow-up period. Pre-post effect sizes for
significant results were only small. Table 3 gives an overview.
Health Care Use Through the 3-Year Follow-up
Period
Although all patients underwent a detailed neurological and
psychosomatic examination, 30 patients (46.2% of n = 65 to T1) re-
ceived further clinical examination in different fields: neurological
(40%), otolaryngological (31.3%), orthopedic (28.1%), internal med-
icine (17.2%), ophthalmic (18.8%), psychosomatic (24.6%), and
others (4.6%). Additional 45 participants (69.2% of n = 65) reported
to have been treated for dizziness during the 3-year follow-up period
by different methods (physiotherapy, relaxation, [psycho]pharmaco-
logical treatment, and psychological interventions). Although all pa-
tients received the recommendation to undergo psychotherapy because
of primary SVD, 36 (62.5% of n = 65) received outpatient psychother-
apy (one third G 12 sessions) and a proportion of 16 (28.6% of n = 65)
received inpatient psychotherapy (93 weeks).
Changes in Distress, QoL, and Vertigo Symptoms
During the 3-Year Follow-up Depending on Changes
in Vertigo- or Dizziness-Specific Handicap
To compare the successful patients regarding vertigo- or
dizziness-specific handicap in the long run (baseline to the 3-year
follow-up) with those without success, we divided the study sample
into three groups by the following definition: increase, the patients with
a worsening of handicap on the VHQ scale (n = 20); unchanged, the
patients with no change and a decrease of 15 points (n = 21); decrease,
loss of 15 points and more (n = 20). Four patients did not provide
valid data on the VHQ. Therefore, they were omitted for the following
analyses. Figures 1 to 3 show changes in distress, QoL, and vertigo or
dizziness symptoms during the 3-year follow-up depending on changes
in handicap.
Dependent on the changes in vertigo- or dizziness-specific
handicap (VHQ) during the 3-year follow-up, the patients with in-
creased handicap also increased in distress (GSI) and differed signifi-
cantly from the patients with decreased handicap (GSI; p G 0.001). The
patients with increased handicap had increased vertigo or dizziness
symptoms (VSS-VER). They significantly differed from the patients
with unchanged or decreased handicap (VSS-VER; p G 0.05). The
patients with increased handicap also increased for autonomic anxiety
(VSS-AA) and differed significantly from the patients with decreased
handicap (VSS-AA; p G 0.05). The patients with decreased handicap
3 years after admission improved in physical (PHC; p G 0.001) and
mental QoL (MHC; p G 0.01). For the PHC, they significantly differed
from the patients with increased handicap, and, in addition, for mental
QoL, they significantly differed from those patients with unchanged
VHQ during the 3-year follow-up.
DISCUSSION
We initially explored 92 patients from our interdisciplinary
outpatient unit for primary SVD. Illness onset was within the last
6 months. The patients received detailed neurological and psycho-
somatic diagnostic examinations, diagnostic explanation, short psycho-
education, and a specific recommendation for outpatient or inpatient
psychotherapy. Three years after admission, we reassessed 65 patients
by postal psychometric survey. We were interested in both persistence
of symptoms, for example, symptom severity, mental comorbidity,
TABLE 3. Distress, QoL, Vertigo, or Dizziness Symptoms and Handicap Through the 3-Year Follow-up Period (n = 59Y63)
Intake 3-Year Follow-up Significance ES (Pre-Post)
GSI (SCL-90-R) 0.71 (0.46) 0.63 (0.44) T(63) = 1.21, p = 0.230 0.137
PHC (SF-36) 40.54 (10.31) 43.76 (12.19) T(62) = 2.66, p = 0.010 0.285
MHC (SF-36) 40.73 (12.20) 42.57 (13.91) T(62) = 1.07, p = 0.291 0.151
Dizziness-specific handicap (VHQ) 48.70 (19.76) 39.49 (24.46) T(60) = 3.60, p = 0.001 0.414
VER (VSS-VER) 0.93 (0.50) 0.77 (0.60) T(59) = 2.07, p = 0.042 0.289
Somatic AA (VSS-AA) 1.31 (0.74) 1.31 (0.89) T(63) = 0.03, p = 0.974 0.005
ES indicates effect size.
TABLE 2. Patient Characteristics: Sociodemographic Data
Study Sample (n = 65) Dropout Sample (n = 27) Total (N = 92)
Sex (female) 30 (46.2%) 14 (51.9%) 44 (47.8%) Fisher’s exact test, p = 0.653
Age, mean (SD), yrs 47.78 (11.88) 41.50 (11.24) 45.94 (11.98) T(90) = 2.34, p = 0.021
Partnership 52 (80.0%) 20 (74.1%) 72 (76.3%) Fisher’s exact test, p = 0.583
Education W23 = 0.49, p = 0.785
Lower than 10th grade 24 (36.9%) 10 (37.0%) 34 (37.0%)
Completed 10th grade 22 (32.3%) 7 (26.0%) 28 (30.4%)
Completed high school 20 (30.8%) 10 (37.0%) 30 (32.6%)
Pensiona 7 (10.9%) 3 (11.1%) 10 (11.0%) Fisher’s exact test, p = 1.000
Unemployeda 6 (9.4%) 3 (11.1%) 9 (9.9%) Fisher’s exact test, p = 1.000
Diagnosis W22 = 0.88, p = 0.645
Anxiety disorder 28 (40.7%) 11 (43.1%) 39 (42.4%)
Depression 14 (21.5%) 4 (14.8%) 18 (19.6%)
Somatoform disorder 23 (35.4%) 12 (44.4%) 35 (38.0%)
Values are presented as number (percentage) unless otherwise indicated.
aMissing data, n = 1.
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dizziness-specific handicap, and subjective QoL, and health care use,
for example, additional diagnostic procedures and treatment modalities.
To determine the prognostic features of the sample, we analyzed three
severity subgroups of the VHQ with respect to dizziness and psycho-
logical strain. The aim of our study was to clarify the risk for chronicity
and its influencing factors, on the one side, and to justify psychothera-
peutic interventions, on the other side.
Symptom Persistence
Three years after intake examination, 36.9% (n = 65) did not or
only seldomly experienced ongoing dizziness or vertigo. A total of
63.1% developed chronic forms of primary SVD, for example, ongo-
ing vertigo, imbalance, light-headedness, fainting, diffuse dizziness,
or uncertainness. A comparison with literature was impossible because
there areVto the best of our knowledgeVno primary SVD reference
groups in prospective follow-up studies. Former prospective studies
investigating heterogeneous subgroups of vestibular vertigo syn-
dromes, secondary SVD, specific phobic postural vertigo, or mixed
etiological samples reported an improvement rate for vertigo and diz-
ziness of between 70% and 80% (Huppert et al., 2005; Kroenke and
Price, 1993; Yardley et al., 1998).
Our contrary findings must probably be explained by the cur-
rent application of more detailed neuro-otological and psychosomatic
procedures or by focusing on single diagnostic subgroups such as
somatoform phobic postural vertigo (Huppert et al., 2005), which is
often a secondary SVD. Unlike previous studies, we were able to re-
liably differentiate primary SVD and secondary SVD from vestibular
vertigo syndromes. We therefore postulate that this difference in im-
provement rates reflects the specific characteristics of our primary
(psychogenic) SVD sample. Vestibular vertigo syndromes or second-
ary SVD with a potentially better prognostic course of disease were
omitted from our study. Nevertheless, Huppert et al. (2005) gave some
evidence for our low recovery rate during 3 years. The authors reported
full recovery in only 27% of phobic postural vertigo during the course
of 8.5 years (Huppert et al., 2005). Kapfhammer et al. (1997) revealed
74% of psychological problems requiring specific psychiatric or psy-
chotherapeutic interventions after a 2.5-year follow-up of phobic
postural vertigo. Nazareth et al. (1999) examined the long-term pro-
gression of (mixed vestibular and psychogenic) dizziness in a general
practice community study (Nazareth et al., 1999). After a period of
18 months, only 20% had improved. Our study therefore confirmed
the high risk for chronicity even in a sample of primary SVD.
Prevalence of Comorbid Mental Disorders
Three years after admission, 40.7% of our patients with pri-
mary SVD had anxiety or phobic disorders, 21.5% were diagnosed
FIGURE 2. Changes in VER and AA (VSS) during the 3-year follow-up depending on changes in vertigo handicap (VHQ). 1) ANOVA:
F(2,56) = 4.881, p = 0.011; Scheffé’s tests: 1 9 2, 3; 2) ANOVA: F(2,60) = 4.726, p = 0.013; Scheffé’s tests: 1 9 3.
FIGURE 1. Changes in symptom severity (GSI) during the 3-year follow-up depending on changes in vertigo handicap (VHQ). 1)
ANOVA: F(2,59) = 9.466, p G 0.001; Scheffé’s tests: 1 9 3.
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with depression, and 35.4% were diagnosed with somatoform dis-
orders. Our analyses revealed no significant differences in all sub-
groups between the baseline and 3-year follow-up measurements.
In correspondence with our data, previous studies postulated anxiety
or phobic disorders as a main predictor for ongoing dizziness and
vertigo (Asmundson et al., 1998; Wiltink et al., 2009; Yardley et al.,
2001). Anxiety-related avoidance behavior significantly correlated
with dizziness.
Improvement of Symptom Severity and Physical
Coping Versus Persistence of Autonomic Anxiety and
Emotional Distress
Regarding the course of primary SVD over time, the patients
improved in dizziness-specific symptom severity (VSS-VER), handi-
cap (VHQ), and physical QoL (PHC). However, the patients showed a
change neither in general distress (GSI) nor in the mental QoL (MHC).
Interestingly, the total group continued to experience high levels of
autonomic anxiety and somatization tendency (VSS-AA). Staab and
Ruckenstein (2007a) postulated the clinical syndrome of autonomic
(exertional) dizziness as a frequent cause of chronic dizziness. Auto-
nomic dysfunction including abnormal heart rate, blood pressure, or
respiratory responses to stress factors even in the absence of syncopal
or presyncopal symptoms were postulated as a subgroup of recurrent
dizziness for lengthy periods of time (Staab and Ruckenstein, 2007a).
Our results lead us to the following questions: Which treatments
did the patients with dizziness use during the period of 3 years? Why
did they improve in physical parameters but not in mental comorbidity
or distress?
Treatment Modalities
A total of 69.2% of the 65 patients with primary SVD received
different forms of treatments: less than two thirds (62.5%) received a
psychotherapeutic one and more than half of the patients received a
pharmacotherapeutic one (51.8%). A large number of patients (46.2%
of n = 65) searched redundant medical diagnostic procedures although
they had been thoroughly informed about the reason and the course of
their mental disorder. These patients underwent most frequently neu-
rological (40%), otolaryngological (31.3%), and orthopedic (28.1%)
examinations. Despite the fact that the total sample received a recom-
mendation for outpatient psychotherapy, less than half of the sample
(45% of n = 65) followed this recommendation for more than 3months’
duration. Summarizing these results, the patients with primary SVD
ineffectively benefited from health care services but showed pro-
nounced somatic illness representations leading to redundant medical
contacts.With this inmind, chronicity was an unstoppable consequence
of mistreatment. Exploring further prognostic features, we analyzed
changes in handicap and coping with respect to psychopathology
and QoL.
Subgroup Analyses Derived From Different Handicap
Developments
The patients with no change or decrease in handicap signifi-
cantly experienced lower levels of symptom severity (VSS-VER) and
distress (GSI) compared with the patients with an increase in handicap.
The patients with a decrease in handicap during a period of 3 years
significantly improved in levels of autonomic anxiety (VSS-AA) and
physical (PHC) and mental (MHC) health QoL. The patients who
enhanced their coping capacity over time obtained more subjective
well-being.
Importance of the Data for Treatment
On the basis of empirical evidence from our findings, we pos-
tulate disease-specific psychotherapy programs for patients with pri-
mary SVD. Diagnostic explanation and short psychoeducation in the
present study did not suffice to reduce both the pronounced somatic
illness representations and high health care use. Thus, the goals of
prospective intervention programs are compliance, self-management,
and empowerment, which are aspired not only by means of providing
information and training skills but also by handling stress and life
events, personal dimensions, somatic comorbidity, psychopathology,
and doctor-patient relationship (Lahmann et al., 2012). In line with
Yardley and Redfern (2001), we prefer a combination of psychotherapy
with physiotherapy for dizziness. A common behavioral response to
vertigo or dizziness is to avoid activities and situations that provoke
symptoms. In addition, anxiety arousal and hyperventilation disinhibit
somatic dizziness symptoms and trigger catastrophizing beliefs, fo-
cused body attention, and cognitive load. Yardley et al. (2001) therefore
demonstrated the effectiveness of a combined vestibular rehabilitation
therapy program focusing on negative beliefs of the consequences of
dizziness. Andersson et al. (2006) successfully combined cognitive
behavioral psychotherapy with vestibular rehabilitation in patients with
chronic dizziness. Our working group showed that a combination of
psychotherapeutic interventions with relaxation and vestibular reha-
bilitation significantly improved maladaptive illness perceptions. The
10-session intervention for primary and secondary SVD led to both
significantly higher feeling of personal control and lower levels of
health care consumption in the 12-month follow-up (Tschan et al.,
2012). Other treatment programs focused on the recovery of vestibular
FIGURE 3. Changes in physical (PHC) and mental (MHC) QoL (SF-36) during the 3-year follow-up depending on changes in
vertigo handicap (VHQ) 1) ANOVA: F(2,58) = 9.005, p G 0.001; Scheffé’s tests: 3 9 1; 2) ANOVA: F(2,58) = 5.753, p = 0.005;
Scheffé’s tests: 3 9 1, 2.
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vertigo syndromes, phobic postural vertigo, or secondary SVD
(Holmberg et al., 2006; Meli et al., 2007; Yardley et al., 2004). To the
best of our knowledge, no international symptom- and complaint-
oriented psychotherapy program has been published for primary SVD.
Limitations and Strengths of This Study
Considering the dropout analyses, the dropout sample (n = 27)
was significantly younger and more burdened by dizziness severity
(VSS-VER) and distress (GSI) than was the 3-year follow-up sample.
The main limitations address the relatively low sample size of 65 and
the questionnaire survey without renewed clinical examinations at the
3-year follow-up. Nevertheless, our response rate of 70.7% was in the
range of studies with comparable follow-up durations (Bleichhardt
et al., 2004; Linden et al., 2005; Wiltink et al., 2007). This is the first
study exploring the long-term course of psychogenic dizziness in a
relatively small but psychometrically and neuro-otologically well-
characterized group of patients with primary SVD.
CONCLUSIONS
The findings of our study lead us to the following conclusions:
a) Primary SVD poses a risk for chronicity; at the 3-year follow-up,
almost two thirds still experienced ongoing dizziness. b) The patients
with primary SVD showed pronounced somatic illness representa-
tions and used redundant diagnostic or medical procedures. c) The
best long-term prognosis regarding symptom severity, dizziness-
specific anxiety, emotional distress, and QoL was found for the pa-
tients with a decreased handicap over time. We suggest the reduction
of dizziness-specific handicap (VHQ) as an important factor for the
long-term effectiveness of future psychotherapy programs.
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